Auxano Medical LLC
$8.8K 10 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Avvisto Therapeutics, LLC
Avvisto Therapeutics, LLC reported $8,858.89 across General Payments, Research, and Ownership to 478 physicians and teaching hospitals across 478 transactions.
- $8.9K Below-median payer
- All-tracks total
- 478 Above-median volume
- Transactions
- 478 Above-median reach
- Recipients
- #1655
- of 1,925 companies
Avvisto Therapeutics, LLC reported $8,858.89 across all CMS Open Payments tracks (General + Research + Ownership) to 478 physicians and teaching hospitals in Program Year 2024 - ranking #1655 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $8,858.89, averaging $18.53 per recipient.
Avvisto Therapeutics, LLC's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
12/100
Total payments
F
10/100
Transaction volume
F
13/100
Physician reach
F
14/100
Payment type diversity
F
10/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer avvisto-therapeutics-llc Avvisto Therapeutics, LLC
$8.9K · #1655/1,925 · 0.0% industry · PY2024
- TOT $8.9K
- RANK #1655
- SHARE 0.0%
- TXN 478
- RCP 478
- CAT 1
- GEN $8.9K
- TOP1 1.3%
- PY 2024
Volume peers
Nearest volume peer: Auxano Medical LLC ($8.8K)
Avvisto Therapeutics, LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Avvisto Therapeutics, LLC
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Avvisto Therapeutics, LLC that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
478 transactions worth $8.9K make "Food and Beverage" the top general-payment category in the 1-category breakdown below, 100.0% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Food and Beverage" leads Avvisto Therapeutics, LLC's 1-category general-payment breakdown at $8.9K, 100.0% of the reported total.
How Avvisto Therapeutics, LLC divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $8.9K | 478 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $553.94 (6.3%) of $8,858.89 in this company's General Payments records across 297 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Avvisto Therapeutics, LLC
The five named recipients with the highest reported General Payments from this company
- 1
Laura S Dankovich
$118.55 across 2 reported transactions
- 2
David Walker
$118.55 across 2 reported transactions
- 3
Eric R Serrano
$114.52 across 3 reported transactions
- 4
Daryana Aronova
$110.24 across 6 reported transactions
- 5
Stella Ilyayeva
$92.08 across 5 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Avvisto Therapeutics, LLC's spend rank (#1655 of 1,925, bottom 14% by spend) and concentration rank (#1,764 of 1,838, bottom 4% least concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Amgen Inc. : $44.9M total payments, HHI 55
- ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) : $10.8M total payments, HHI 52
- Mylan Specialty L.P. : $1.4M total payments, HHI 51
- Virtus Pharmaceuticals LLC : $19.8K total payments, HHI 50
- Madrigal Pharmaceuticals : $4.5M total payments, HHI 49
- Electronic Waveform Lab, Inc. : $32.0K total payments, HHI 47
- Avvisto Therapeutics, LLC (this company) : $8.9K total payments, HHI 47
- Neurocrine Biosciences, Inc. : $14.2M total payments, HHI 47
- W. L. Gore & Associates, Inc. : $5.4M total payments, HHI 47
- Aucta Pharmaceuticals, Inc. : $25.2K total payments, HHI 46
- Axsome Therapeutics, Inc. : $12.2M total payments, HHI 45
- Sumitomo Pharma America, Inc. : $3.8M total payments, HHI 45
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Avvisto Therapeutics, LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Avvisto Therapeutics, LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Avvisto Therapeutics, LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
Digestive Care, Inc.
$9.0K 333 recipients
Compare payment profiles
Biocartis US, Inc
$9.2K 16 recipients
Compare payment profiles
Prolaio, Inc.
$8.5K 15 recipients
Compare payment profiles
G21 Srl
$9.2K 9 recipients
Compare payment profiles
Darco International, Inc.
$8.5K 6 recipients
Compare payment profiles
Put this to use
Avvisto Therapeutics, LLC ranks #1655 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just Avvisto Therapeutics, LLC. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.